Elliot Newman is an Oncology physician affiliated with Northwell Health. OpenAlex indexes 151 publications with 2,972 citations (h-index 29); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
530 1st Ave
6c
New York, NY 100166402
Telephone
212-263-7302Registry record last updated 14 Dec 2011.
Clinical trials
- Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer
Sponsor: NYU Langone Health
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20254 payments
- Delcath SystemsProgram year20251 payment
- Delcath SystemsProgram year20244 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2004–2005 per NIH RePORTER. The latest:
- CPT-11 AND CISPLATIN IN ADVANCED GASTRIC CARCINOMA
New York University School of Medicine
FY2005$19,576M01RR000096 - CPT-11 and Cisplatin In Advanced Gastric Carcinoma
New York University School of Medicine
FY2004$7,622M01RR000096
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Modified 5-Item Frailty Index (mFI-5) may predict postoperative outcomes after pancreatoduodenectomy for pancreatic Cancer
Langenbeck s Archives of Surgery
2024 - Robotic vs open distal pancreatectomy: A multi‐institutional matched comparison analysis
Journal of Hepato-Biliary-Pancreatic Sciences
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Peter Gregersen
Northwell Health
Louis Kavoussi, MD
Northwell Health
David Eidelberg, MD
Northwell Health
Francisco Esteva, MD, PhD
Northwell Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”